HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $97 | -66.7% | 64,528 | -44.6% | 0.01% | -72.2% |
| Q4 2022 | $291 | -99.9% | 116,574 | +34.8% | 0.04% | -25.0% |
| Q3 2022 | $365,000 | -35.1% | 86,459 | -57.1% | 0.05% | -42.9% |
| Q2 2022 | $562,000 | -33.7% | 201,424 | +35.8% | 0.08% | -26.3% |
| Q1 2022 | $848,000 | +170.1% | 148,272 | +331.3% | 0.11% | +192.3% |
| Q4 2021 | $314,000 | -19.5% | 34,374 | -5.7% | 0.04% | -2.5% |
| Q3 2021 | $390,000 | -58.2% | 36,442 | -39.4% | 0.04% | -61.9% |
| Q2 2021 | $933,000 | +72.5% | 60,093 | +80.1% | 0.10% | +16.7% |
| Q1 2021 | $541,000 | -13.4% | 33,369 | -20.9% | 0.09% | -13.5% |
| Q3 2020 | $625,000 | +31.6% | 42,177 | +4.2% | 0.10% | -12.6% |
| Q1 2020 | $475,000 | -26.7% | 40,459 | +46.8% | 0.12% | +58.7% |
| Q4 2019 | $648,000 | – | 27,559 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 8,648,252 | $238,692,000 | 35.08% |
| Broadfin Capital, LLC | 1,581,416 | $43,647,000 | 6.80% |
| Tavio Capital LLC | 351,729 | $9,708,000 | 4.58% |
| Mesirow Financial Investment Management, Inc. | 33,389 | $922,000 | 3.88% |
| Rubric Capital Management LP | 1,510,008 | $41,676,000 | 3.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,666,229 | $45,988,000 | 3.63% |
| First Light Asset Management, LLC | 473,275 | $13,062,000 | 2.87% |
| Asymmetry Capital Management, L.P. | 77,346 | $2,135,000 | 2.67% |
| Copernicus Capital Management, LLC | 108,000 | $2,981,000 | 2.38% |
| BRIDGER MANAGEMENT, LLC | 1,277,560 | $35,261,000 | 2.14% |